Form 4 for DERM Journey Medical Corp
Accepted 2022-07-25 00:00:00 ET · period of report 2022-07-21 · accession 0001104659-22-082285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-25 | 2022-07-21 | DERM | De Paolantonio Ernest Robert | CFO | A - Grant | $0.00 | +150.0K | 270.0K | +125% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2022-07-21 | A | A | 150,000 | $0.00 | 270,000 | D | — | — | (F1) On July 21, 2022, the reporting person was granted 150,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan. One-fourth of the shares will vest on each of July 21, 2023, 2024, 2025 and 2026, subject to the reporting person's continuous service with the Issuer. (F2) Includes restricted stock units, 150,000 of which will vest over various time periods as set forth in footnote 1, and 120,000 of which will vest in three increments as follows: (1) 40,000 units on October 1, 2022, (2) 40,000 units on October 1, 2023, and (3) 40,000 units on October 1, 2024. |